1,109 reports of this reaction
2.6% of all CALCITRIOL CAPSULES 0.25 MCG reports
#2 most reported adverse reaction
DIARRHOEA is the #2 most commonly reported adverse reaction for CALCITRIOL CAPSULES 0.25 MCG, manufactured by Strides Pharma Science Limited. There are 1,109 FDA adverse event reports linking CALCITRIOL CAPSULES 0.25 MCG to DIARRHOEA. This represents approximately 2.6% of all 42,159 adverse event reports for this drug.
Patients taking CALCITRIOL CAPSULES 0.25 MCG who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is a less commonly reported adverse event for CALCITRIOL CAPSULES 0.25 MCG, but still significant enough to appear in the safety profile.
In addition to diarrhoea, the following adverse reactions have been reported for CALCITRIOL CAPSULES 0.25 MCG:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 1,109 FDA reports for CALCITRIOL CAPSULES 0.25 MCG. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 2.6% of all adverse event reports for CALCITRIOL CAPSULES 0.25 MCG, making it one of the most commonly reported side effect.
If you experience diarrhoea while taking CALCITRIOL CAPSULES 0.25 MCG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.